Please wait while we open this resource.
CONTROVERSIES SURROUNDING THE USE OF CARVEDILOL AND OTHER BETA BLOCKERS IN THE MANAGEMENT OF PORTAL HYPERTENSION AND CIRRHOSIS — OslerMarket